Motegi SI, Sekiguchi A, Sekine Y, Nakayama H, Suzuki K, Ishikawa O. Prevalence and clinical characteristics of overactive bladder in systemic sclerosis. Modern rheumatology. 2019. 30. 2. 1-5
Ishikawa M, Motegi SI, Toki S, Endo Y, Yasuda M, Ishikawa O. Calciphylaxis and nephrogenic fibrosing dermopathy with pseudoxanthoma elasticum-like changes: Successful treatment with sodium thiosulfate. The Journal of dermatology. 2019. 46. 7. e240-e242
Akihito Uehara, Sei-Ichiro Motegi, Hirohisa Ishibuchi, Yuta Inoue, Shintaro Saito, Aina Oka, Chikako Kishi, Masahito Yasuda, Taro Yamashita, Osamu Ishikawa. Successful treatment with i.v. immunoglobulin for localized cutaneous immunoglobulin light chain kappa-positive amyloidosis associated with dermatomyositis. Journal of Dermatology. 2018. 45. 5. e102-e103
Yuko Kuriyama, Mai Hattori, Takeki Mitsui, Hajime Nakano, Daisuke Oikawa, Fuminori Tokunaga, Osamu Ishikawa, Akira Shimizu. Generalized verrucosis caused by various human papillomaviruses in a patient with GATA2 deficiency. Journal of Dermatology. 2018. 45. 5. e108-e109
Akihito Uehara, Sei-Ichiro Motegi, Hirohisa Ishibuchi, Yuta Inoue, Shintaro Saito, Aina Oka, Chikako Kishi, Masahito Yasuda, Taro Yamashita, Osamu Ishikawa. Successful treatment with i.v. immunoglobulin for localized cutaneous immunoglobulin light chain kappa-positive amyloidosis associated with dermatomyositis. Journal of Dermatology. 2018. 45. 5. e102-e103
Yuko Kuriyama, Mai Hattori, Takeki Mitsui, Hajime Nakano, Daisuke Oikawa, Fuminori Tokunaga, Osamu Ishikawa, Akira Shimizu. Generalized verrucosis caused by various human papillomaviruses in a patient with GATA2 deficiency. Journal of Dermatology. 2018. 45. 5. e108-e109
Beneficial effect of botulinum toxin A on Raynaud’s phenomenone in Japanese patients with systemic sclerosis: a prospective, open label trial.
(the 2015 ACR/ARHP Annual Meeting 2015)
Parameters That Predict Worsening of Skin Thickness in Patients with Early Diffuse Cutaneous Systemic Sclerosis.
(the 2015 ACR/ARHP Annual Meeting 2015)